Coherus Oncology
CHRS
CHRS
161 hedge funds and large institutions have $623M invested in Coherus Oncology in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 60 increasing their positions, 55 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $744M → $623M (-$121M)
39% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 31
Holders
161
Holding in Top 10
–
Calls
$1.18M
Puts
$1.26M
Top Buyers
| 1 | +$13.3M | |
| 2 | +$8.9M | |
| 3 | +$8.69M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.65M |
| 5 |
JPMorgan Chase & Co
New York
|
+$3.01M |
Top Sellers
| 1 | -$16M | |
| 2 | -$6.12M | |
| 3 | -$5.02M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$3.99M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.76M |